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Reactive oxygen species (ROS) have long been studied as destructive agents
in the context of nervous system ageing, disease and degeneration. Their roles
as signalling molecules under normal physiological conditions is less well
understood. Recent studies have provided ample evidence of ROS-regulating
neuronal development and function, from the establishment of neuronal polar-
ity to growth cone pathfinding; from the regulation of connectivity and synap-
tic transmission to the tuning of neuronal networks. Appreciation of the
varied processes that are subject to regulation by ROS might help us under-
stand how changes in ROS metabolism and buffering could progressively
impact on neuronal networks with age and disease.
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The increase in atmospheric oxygenation is presumed
to have set the pace of evolutionary change. The sym-
biotic acquisition of mitochondria 1.45 billion years
ago generating the eukaryota further allowed diversifi-
cation via the efficient metabolic use of diatomic oxy-
gen. Reactive oxygen species (ROS), highly reactive
molecules and free radicals derived from molecular
oxygen are produced as natural by-products of normal
respiratory metabolism, with the major source being
the mitochondria. Mitochondria leak bursts of ROS as
a function of respiration [1] pointing to a link between
metabolism and ageing-related damage. Other
subcellular locations of ROS production continue to
be identified and include the endoplasmic reticulum
(ER) [2], peroxisome [3], the cytosol [4], plasma mem-
brane [5] and extracellular space [6]. However, there is
a growing opinion and body of evidence that ROS can
act as physiological signalling molecules. In this review
we will focus on the role of ROS as a physiological
signal in the nervous system during development and
as a regulator of neuronal function.
By their highly reactive nature, ROS are damaging
to the cell, oxidising proteins, lipids and DNA and are
normally regarded as detrimental to cell function.
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Indeed, an overwhelming of the defences against ROS
is termed oxidative stress and is commonly associated
with cellular damage seen in neurodegenerative disor-
ders, including Parkinson’s [7] and Alzheimer’s disease
[8]. ROS and the accumulation of ROS-related damage
are also associated with ageing; oxidised lipids, DNA
damage and the accumulation of lipofuscin (the ‘aging
pigment’, autofluorescent material found in endosomes
consisting of oxidised lipids, proteins, transition metals
and senescent mitochondria) [9]. Increasing evolution-
ary complexity and concomitant demand for oxygen-
dependent energy production via reduction–oxidation
(redox) reactions also produced a diversification in
defence mechanisms against ROS. This is particularly
notable in energy demanding tissues such as heart and
liver. The nervous system is anomalous in this frame-
work as nerve cells are very energy demanding yet at
the same time inadequately equipped with antioxidant
defence [10,11]. Interestingly, much of the ROS
defence within the nervous system occurs in glia [12].
It is becoming increasingly apparent, however, that
evolution may have made a virtue out of a necessity
and co-opted ROS for cellular signalling mechanisms.
For such a framework lowered antioxidant defence or
ROS buffering in neurons would be permissive and
necessary.
Regulation of ROS in the nervous
system, the case for the defence
Studies of ROS in the nervous system have primarily
focused on ROS as damaging agents and the defence
against ROS. Protection against ROS is mediated by
multilayered constitutive and adaptive forms of
defence. In the brain, static defences against ROS gen-
erally are seen to be (a) constitutive and enzymatic as
seen in the standing high concentrations of enzymes
such as superoxide dismutases, catalases, thioredoxin
reductases and glutathione peroxidases or (b) constitu-
tive and nonenzymatic as mediated by defence mole-
cules (termed ROS scavengers) present in the cell, via
synthesis or diet, such as alpha-tocopherol (vitamin E),
ascorbic acid, ß-carotene and tetrahydrobiopterin
(BH4). BH4 is a molecule of particular interest. For
example, BH4 is a highly sensitive scavenger of H2O2
and Hydroxyl ions, while also important for the syn-
thesis of the neurotransmitters dopamine, serotonin
and noradrenaline. This suggests a functional link
between ROS abundance, buffered by BH4 levels, and
neurotransmitter function (for review see [13]). A sec-
ond set of defence mechanisms is adaptive and medi-
ated by transcription factors [14]. Two pathways are
prominent: (a) the NRF2/Keap system, predominant
in glial cells [12] and (b) the Jun-N-terminal Kinase
(JNK)/AP-1 system, seen to be a major protective
mechanism in neurons. Both promote the transcription
of genes encoding antioxidant response proteins. For
example, NRF2 promotes the expression of glu-
tathione-S-transferases in glia [15] while in neurons
AP-1 activation upregulates sulfiredoxin [16]. NRF2
activity in glia mediates neuronal protection in a
nonautonomous manner, partly through the ensheath-
ing nature of symbiotic glial–neuron interactions.
Indeed, keeping NRF2 function low in neurons allows
dendritic and synaptic development and their regula-
tion via redox-sensitive signalling pathways, such as
JNK/AP-1 and WNT [17].
Neuronal polarity
Most neuronal cell types are explicitly polarised,
endowed with a major axonal neurite that mediates
long-range connectivity and is primarily presynaptic,
dedicated to passing on information, while the
somato-dendritic compartment of the cell is composed
of branched smaller diameter neurites that are largely
postsynaptic. The establishment of neuronal polarity
has until recently mostly been studied in vitro, using
low-density cultures of cortical and hippocampal neu-
rons. Under such conditions neuronal polarity first
manifests with the emergence of a primary neurite,
which extends more rapidly than others and develops
into the axon, while the other minor neurites adopt
postsynaptic dendritic characteristics. Several signalling
pathways, including TGF-ß, growth factors (e.g.
BDNF), LKB and PI3 kinases, have been implicated
in bringing about and maintaining asymmetries of the
cytoskeleton. Characteristically, axons contain micro-
tubules whose plus ends face away from the cell body,
while dendrites have microtubules of mixed (mammals)
or opposite polarity (e.g. Drosophila and Caenorhabdi-
tis elegans; for reviews see [18,19]). Perhaps inspired by
work from other systems that have associated
NADPH oxidase-generated ROS with the regulation
of cell polarisation and growth, for example, Arabidop-
sis hair cell outgrowth [20] and the enforcement of api-
cal dominance in Aspergillus hyphae [21], ROS have
been investigated as signals regulating the polarisation
of neurons. Indeed, in vitro studies suggest that ROS
produced by NADPH oxidases were required along-
side growth factors for the differentiation of neuronal
characteristics by PC12 and SH-SY5Y cells, such as
axonal outgrowth [22–25]. In vivo, gene expression
profiles show that subunits of the NOX2 NADPH oxi-
dase complex are present at the right place and time in
mouse and rat embryonic hippocampal neurons
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[26,27]. In the context of neuronal differentiation
mediated by nerve growth factor (NGF), Neuregulin
or Retinoic Acid ROS appear to be permissive, acting
in parallel to these growth factors. As documented for
several growth factors, ROS can enhance downstream
kinase signalling by inhibition of phosphatases, whose
active sites contain cysteines that are susceptible to
oxidation [28]. The activity of protein kinases is critical
during cellular polarisation, meditating positive feed-
back loops and signal amplification. Multiple path-
ways converge onto PI3 kinase, which is enriched at
the tip of the future axon as neurons adopt a polarised
morphology [29,30] (reviewed in [18]). Interestingly,
PI3 kinase signalling can be regulated by ROS, by
redox-mediated inhibition of the phosphatase and ten-
sin homolog (PTEN), which antagonises the PI3
kinase product phosphoinositide-3-phosphate [31,32].
Studies on embryonic hippocampal neurons and
cerebellar granule cells in culture have underpinned
the idea that ROS contribute to the establishment of
neuronal polarity. As cerebellar granule cells differenti-
ate during the first 3 days in vitro overall ROS levels
increase and become specifically enriched at growth
cones and other cytoskeletally dynamic sites. This is
paralleled by a ROS-dependent rise in Tau and MAP2
expression levels, which are representative of axonal
and dendritic cytoskeletal specialisation [33]. Underlin-
ing a requirement for ROS in these processes, neurons
derived from NOX2 knockout mice showed reduced
neurite length compared to control cells [33]. Similarly,
in embryonic hippocampal neurons pharmacological
or genetic reduction in NADPH oxidase activity, e.g.
by expression of the dominant negative DNp22phox
regulatory subunit, led to delayed and reduced axon
outgrowth [26]. Conversely, overactivation of NADPH
oxidase by overexpression of the accessory protein
p47phox promoted axonal growth [34]. These studies
suggest that NOX2 activity could indeed contribute to
neuronal polarisation and promote neurite outgrowth.
The mechanisms by which physiological levels of
ROS support neurite outgrowth and axon specification
appear to involve release of calcium from intracellular
stores, a potent second messenger regulating cytoskele-
tal organisation and dynamics (reviewed in [35,36]).
Short respiratory bursts of NADPH oxidase-generated
ROS promote calcium release by redox modification
of ryanodine (RyRs) and inositol-3-phosphate recep-
tors (IP3Rs). These in turn lead to increased expres-
sion of Rac1, an activator of the NOX2 complex, thus
generating a positive feedback loop that can convert
initially transient ROS bursts into sustained ROS acti-
vation and high levels of intracellular calcium [34];
(Fig. 1). However, the extent to which ROS signalling
promotes the establishment of neuronal polarity
in vivo remains to be determined. Phenotypes of
NADPH oxidase knockout and RNAi knockdown
experiments in several experimental animal models
suggest that removal of any one NADPH oxidase still
allows the nervous systems to form and function
remarkably well, at least to a level sufficient for sur-
vival under laboratory conditions [37,38]. This could
indicate a degree of functional redundancy. It also sug-
gests that ROS might have a modulatory role rather
than being critically required for the establishment of
neuronal polarity. This would not be entirely surpris-
ing, as during nervous system development neural pro-
genitor cells and their progeny are invariably located
within asymmetric environments where local enrich-
ment of numerous cues, including cell adhesion and
extracellular matrix proteins, can contribute to cellular
polarisation [39–41] (for review see [18]).
Cytoskeletal modifications by ROS and growth
cone pathfinding
Reactive oxygen species can regulate cytoskeletal
change at multiple levels; directly via redox modifica-
tion of structural cytoskeletal proteins and indirectly
by modification of proteins or signalling pathways that
regulate cytoskeletal dynamics. For example, actin and
tubulin monomers contain multiple cysteine and
methionine residues exposed to the cytoplasm that are
subject to redox modifications, notably glutathionyla-
tion, nitrosylation and carbonylation [42–49]. Indeed,
all major cytoskeletal elements and many cytoskeleton-
associated proteins are subject to direct redox modifi-
cations of some kind [50–52], with substantial fractions
of actin, tubulin and neurofilaments found glu-
tathionylated under normal physiological conditions
[53]. The question of which residues are modified,
under what conditions and how this impacts on pro-
tein function and dynamics remains live. For alpha-
actin purified from rabbit muscles, in vitro and cell cul-
ture studies have shown Cys 374 sensitive to glu-
tathionylation, leading to a reduced rate of actin
polymerisation and altered actin dynamics [44,54].
Actin Cys 374 glutathionylation has been proposed to
occur in response to growth factor and integrin-stimu-
lated signalling following interactions with the extra-
cellular matrix [54]. This actin modification is thought
to regulate the disassembly of the actinomyosin com-
plex during cell spreading [52]. Along the same lines,
disruption of protein deglutathionylation by mutation
of glutaredoxin 1 (Grx1), the gene coding for an
enzyme that catalyses actin deglutathionylation, led to
reduced actin polymerisation and impaired
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polarisation, chemotaxis, adhesion, and phagocytosis
by neutrophils. Conversely, blocking NOX activity led
to increased formation of filamentous actin [55]. Thus,
ROS have increasingly been recognised as important
regulators of actin dynamics.
One of the principal ROS sources in neurons is
NAPDH oxidases. Their activity is highly regulated,
making them prime candidates as regulators of growth
cone cytoskeletal dynamics (for reviews see [56] and
[57]). How NADPH oxidase-generated ROS regulate
cytoskeletal dynamics in neuronal growth cones
remains poorly understood. Pharmacological inhibi-
tion of NADPH oxidase activity or lowering cytosolic
ROS levels led to reduced F-actin content, retrograde
flow and neurite outgrowth. Few studies have docu-
mented the localisation of NOX complex components
in neuronal growth cones in vitro, none as yet in vivo
[58,59]. In cultured Aplysia bag cell neurons the main
enzymatic subunit of a NOX2-type NADPH oxidase,
NOX2/gp91phox, was seen localised to the plasma
membrane, largely distinct from the regulatory subunit
p40phox found associated with filopodial actin bundles
(Fig. 1). Interestingly, a local stimulus of growth cone
interaction with apCAM-coated beads triggered colo-
calisation of both subunits to the site of growth cone–
substrate interaction. Thus, in growth cones NADPH
oxidase subunits are localised to the periphery at sites
of actin assembly [58]. Their activity is regulated by
multiple pathways, including activation following
translocation of regulatory subunits, such as p40phox
or Rac1, but also by other signalling pathways, such
as protein kinase C (PKC) [59]. The extent to which
local NAPDH oxidase activation regulates growth
cone dynamics directly, via oxidation of actin and
tubulin, or indirectly, through modulation of other
signalling pathways, remains to be seen. Both are
likely. A study using cultured marsupial kidney cells
demonstrated that hydrogen peroxide-induced chemo-
taxis and filopodial dynamics were in large part indi-
rectly regulated by ROS via local extracellular signal–
regulated kinase (ERK) pathway activation, which
promoted actin retrograde flow by differential activa-
tion and recruitment of cofilin and the Arp2/3 nucle-
ator at the leading edge [60]. It is conceivable that
ROS signalling in the nervous system might similarly
be utilised for noncell autonomous communication,
either during the development of synaptic connections
or their subsequent adjustment. For example, in a
mouse model for multiple sclerosis, persistent activa-
tion of NOX2/gp91phox in microglia leads to the
impairment of synaptic plasticity in adjacent hip-
pocampal neurons [61].
Thus far, the clearest evidence for post-translational
redox modification of cytoskeletal proteins directing
growth cone pathfinding derives from studies of Sema-
phorin-Plexin signalling. The cytoplasmic tail of Plexin
interacts with the NADPH-dependent monooxygenase,
molecule interacting with CasL (MICAL), which is
activated upon binding of Semaphorin guidance cues
[62–67] (for review see [68]; Fig. 1). Elegant experi-
ments by the Terman laboratory and collaborators
demonstrated that the amino-terminal NADPH-depen-
dent redox domain of MICAL-1 binds F-actin and
directly oxidises the methionine residues Met44 and
Met47 [64,65]. These redox modifications are regulated
and can be reversed by a methionine sulfoxide reduc-
tase, (MsrB/SelR), which catalyses the reduction of
methionine sulfoxide to methionine [66]. MICAL-1-
mediated oxidation of actin weakens inter-actin
contacts while simultaneously increasing the binding
affinity of the F-actin severing protein cofilin by more
than an order of magnitude. This synergistic effect of
actin destabilisation by oxidation and concomitantly
increased binding of cofilin promotes F-actin disassem-
bly. In addition, MICAL-mediated oxidation decreases
the capacity of actin for repolymerisation, thus further
impacting on the dynamics of the actin cytoskeleton
[67]. Thus, Semaphorin-Plexin guidance cue–receptor
interactions are directly transduced to redox modifica-
tion of the actin cytoskeleton, leading to F-actin disas-
sembly and altered reassembly dynamics.
In addition, MICAL activation also impacts on the
microtubule cytoskeleton via another binding partner,
collapsin response mediator protein 2 (CRMP2).
CRMP2 is responsible for Semaphorin-induced growth
cone collapse [69] and interacts with tubulin heterodi-
mers regulating microtubule dynamics 1 [62,70]. Cur-
rent data suggest that MICAL-1 binds CRMP2, and
that upon MICAL monooxygenase activation (e.g. by
Semaphorin binding to Plexin), hydrogen peroxide is
produced that oxidises CRMP2. Oxidation of CRMP2
promotes formation of disulfide-linked CRMP2
homodimers, which interact with thioredoxin, which in
turn promotes their phosphorylation by GSK-3ß,
microtubule disassembly and growth cone collapse
[71]; (Fig. 1). In summary, direct redox modifications
of cytoskeletal elements, notably actin and tubulin, as
well as of regulators of cytoskeletal dynamics, such as
CRMP2, lie at the heart of Semaphorin-Plexin growth
cone guidance. It is conceivable that redox modifica-
tion of cytoskeletal proteins extends to other guidance
cue signalling pathways, either directly or in a modula-
tory capacity where the cellular redox state determines
growth cone responses to extracellular cues.
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Connectivity and structural plasticity
For decades ROS have been implicated in neurodegen-
erative conditions, largely thought of as destructive
agents [72,73]. Increasingly ROS have also been viewed
as regulators and modulators of signalling pathways
and gene expression, of which many are known to reg-
ulate neuronal growth and plasticity (reviewed in
[56,57,74]). Several years ago we provided the first
direct in vivo evidence of ROS as regulators of synap-
tic terminal growth, under pathological conditions in
an experimental animal model (Drosophila) for lysoso-
mal storage disease [75]. The study demonstrated that
oxidative stress resulting from lysosomal storage dys-
function led to activation of the JNK cascade and acti-
vation of the immediate early genes c-Jun and c-Fos
(AP-1) which in turn led to altered growth of neuro-
muscular junction terminals [75]. Along with a prior
study by Sanyal and colleagues [76], this work identi-
fied AP-1 as the major adaptive response to ROS in
neurons. The JNK/AP-1 signalling pathway has long
been known to be critical in many neuronal functions
and is a well-known mediator of synaptic and oxida-
tive stress responses (reviewed in [74]). AP-1 is a het-
erodimer composed of the leucine-zipper transcription
factors Fos and Jun. Fos is one of the major immedi-
ate early transcription factors mediating long-term
synaptic changes during long-term potentiation (LTP)
[77,78], although the actual mechanism inducing JNK
phosphorylation and subsequent AP-1 activation in
this process remains obscure. Activation of JNK/AP-1
by oxidative stress is thought to reinforce autophagy,
and many genes encoding autophagy proteins are
direct transcriptional targets of AP-1 [79]. Some evi-
dence suggests that activation of autophagy via the
oxidative stress-induced JNK/AP-1 pathway can regu-
late synaptic terminal size and strength at the Droso-
phila larval neuromuscular synapse [75,76,80]. The
data point to the importance of the JNK/AP-1
Fig. 1. Regulation of the growth cone cytoskeleton by ROS. (1) Semaphorin binding to Plexin activates MICAL monooxygenase. MICAL
interactions with F-actin lead to oxidation of the conserved amino acid Met44 [64]. Oxidation of actin destabilises F-actin filaments and
promotes binding of the actin severing protein Profilin, thus promoting F-actin disassembly [67]. Oxidised actin monomers have a reduced
propensity for polymerisation. MICAL redox activity is opposed by the MsrB enzyme SelR, which specifically reduces Met-44-R-sulfoxide
[66]. MICAL activation via Semaphorin-Plexin binding also generates H2O2 that can oxidise CRMP2, enabling it to form a disulfide-linked
homodimer and to transiently interact with Thioredoxin, which stimulates phosphorylation of CRMP2 by glycogen synthase kinase-3,
promoting CRMP2 modification of microtubules and growth cone collapse [71]. (2) Superoxide produced by the NOX2 NADPH oxidase
catalytic subunit (gp91phox) is regulated by translocation of the p40phox regulatory subunit from its association with F-actin to the plasma
membrane upon growth cone engagement with a substrate or guidance cue [58]. Converted into hydrogen peroxide by extracellular
superoxide dismutase (EC-SOD), H2O2 enters the cytoplasm via aquaporins and can oxidise cytoskeletal proteins (e.g. F-actin) [132,133]. (3)
H2O2 also modifies RyRs and IP3Rs triggering release of calcium from internal stores in the ER. (4) Changes in intracellular calcium modify
activities of cytoskeletal regulatory proteins, directly or indirectly, e.g. via the regulation of Calcium/calmodulin-dependent kinase II (CamKII) or
the phosphatase calcineurin or activation of the protease calpain. Elevated calcium levels also lead to expression of the cytoskeletal and
NADPH oxidase regulator Rac1, thus generating a positive feedback loop that can amplify and sustain transient respiratory bursts [34].
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pathway as regulating synaptic function and to ROS
as critical upstream signals during normal physiologi-
cal conditions as well as under oxidative stress.
In a follow-up study we since asked whether ROS
also act as regulators of synaptic terminal growth and
plasticity under normal physiological conditions, which
until now has remained largely unexplored. Indeed, we
found that ROS, in particular hydrogen peroxide, are
necessary for activity-induced synaptic terminal growth
and are sufficient to drive synaptic terminal growth
[81]. Specifically, overactivation of motoneurons leads
to increased mitochondrial ROS levels at the presynap-
tic neuromuscular junction of Drosophila larvae, previ-
ously also reported for cultured hippocampal neurons
[82,83]. In Drosophila larvae, activity-generated ROS
promote altered synaptic terminal growth, generating
more, albeit smaller synaptic varicosities (boutons)
along with a reduction in the number of synaptic
release sites. Postsynaptic dendrites similarly undergo
homeostatic structural adjustments in response to
activity-generated ROS, leading to smaller dendritic
arbours, which we previously showed equates to
reduced synaptic input sites and reduced synaptic drive
[84]. The signalling and downstream effector pathways
of neuronal activity-generated ROS are only just being
sketched out. We found that neuronal ROS signal via
the conserved redox-sensitive protein DJ-1ß, a homo-
logue of vertebrate DJ-1 (PARK7) [85,86], which
appears to act as a neuronal redox sensor. Oxidation
of DJ-1ß increases inhibitory interactions with the
phosphatase PTEN thus leading to disinhibition of
PI3kinase signalling, a known regulator of synaptic
terminal growth [87–90]. Whether changes in dendritic
growth are also regulated by PTEN-PI3kinase as a
ROS effector pathway, and how synaptic terminal
growth might be coupled to synaptic connectivity
remain to be determined. Importantly, ROS are obli-
gate signals for activity-regulated structural plasticity
of synaptic terminals, either instructive or permissive.
Targeted abrogation of neuronal ROS signalling in
Drosophila larval motoneurons, by expression of a
modified form of the DJ-1b redox sensor (the con-
served Cysteine 106 mutated to a nonoxidisable Ala-
nine [86,91]) prevented the locomotor network from
adjusting homeostatically in response to increased
levels of network activity, resulting in abnormal motor
output [81].
Precisely how neuronal activation leads to the gener-
ation of ROS signals is not clear and is likely context
specific. In general, ROS are formed as obligate by-
products of mitochondrial respiratory ATP synthesis,
by ‘leakage’ of the electron transport chain [72]. Thus,
mitochondrial ROS could potentially provide neurons
with a readout of their energetic demand. In addition,
NMDA receptor stimulation has been shown to trigger
ROS generation by either mitochondria [92,93] or
NADPH oxidases [94]. NADPH oxidase activity is
subject to complex regulatory pathways, of which
many are associated with neuronal activation, such as
elevated intracellular calcium levels, Protein kinases C
and A, as well as calmodulin and calcium/calmodulin-
dependent kinase II (CamKII) [34,56,95–98].
It has become increasingly evident that during nor-
mal nervous system development and function ROS act
as second messengers that regulate multiple aspects,
from neuronal polarity and axon growth cone beha-
viour to structural plasticity. As such ROS have more
recently been investigated as potentially involved in the
aetiology of psychiatric disorders with neurodevelop-
mental origins. For example, in mammalian brains cor-
tical parvalbumin-expressing inhibitory interneurons
(PVIs) are critical to the excitation–inhibition balance
and therefore function of many cortical networks.
These fast-spiking neurons are arguably highly suscepti-
ble to ROS generated by mitochondrial ATP metabo-
lism and it is thought that their surrounding
perineuronal nets confer protection of the PVIs to
oxidative challenges [99]. Imbalances in ROS metabo-
lism and buffering are thought of as potentially impact-
ing on the development of cortical networks during so-
called critical periods, leading to sub-optimal network
performance and neuropsychiatric disorders [100]. Sup-
porting this hypothesis are reports of post mortem brain
tissue from patients with schizophrenia, bipolar or aut-
ism spectrum disorder exhibiting reductions in cortical
PVIs [101–103]. Moreover, a recent study did indeed
find that conditions of elevated oxidative stress pre-
ceded and correlated with reduced integrity of PVIs in
mouse models for these disorders [104].
Synaptic transmission and plasticity
Synaptic plasticity describes the ability of synapses to
adjust their strength, connectivity and structure in
response to previously experienced activity. The inher-
ent plasticity of neurons is key to neuronal network
development and in networks allows for adaptation,
memory and learning. Synaptic strength may be
enhanced or reduced depending upon the neuronal
context and the nature of stimulation, the best-studied
examples being LTP and long-term depression (LTD).
LTP was originally described following repetitive stim-
ulation of the perforant path fibres to the dentate area
of the hippocampus [105]. The high-frequency stimula-
tion (HFS) used for induction of LTP results in open-
ing of NMDA receptors and thus elevated intracellular
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Ca2+. This leads to the adjustment of synaptic
strength via direct and transcriptionally regulated mod-
ification of synaptic proteins, and changes in the com-
position of synaptic protein complexes (for review see
[57,106]).
A role for ROS in synaptic plasticity has been
demonstrated in various model systems and areas of
the nervous system (Fig. 2). ROS production is ele-
vated in hippocampal slice preparations following
increased neuronal activity, NMDA receptor activa-
tion and subsequent LTP [92]. In mouse hippocampus
NMDA receptor activation triggers ROS generation
through the NOX2 NADPH oxidase, regulated by
PKC [94]. Importantly, acute application of cell per-
meable superoxide scavengers can block HFS-induced
LTP in hippocampal slices. Dysregulation of ROS via
transgenic mis-expression of SOD1 or Catalase simi-
larly blocked LTP, suggesting that LTP requires ROS
and at the same time is sensitive to the cellular redox
state [107–110]. Conversely, bath applied elevation of
ROS in hippocampal slices can be sufficient to induce
LTP in the CA1 region [111]. ROS are also required
and sufficient for the induction and maintenance of
spinal cord LTP, contributing to central sensitisation
and chronic neuropathic pain [112]. Interestingly, in
cerebellar Purkinje neurons superoxide is required for
LTD, although in these cells synaptic depression (as
opposed to potentiation) requires elevated intracellular
calcium concentration [113].
The specific protein targets of ROS for regulating
synaptic plasticity and the interplay between Ca2+ and
ROS-regulated pathways are exciting and thriving
research fields [57]. In particular, the link between
ROS and Ca2+-regulated plasticity signalling pathways
raises the possibility that synaptic redox state provides
a permissive environment that, depending upon con-
text, positively or negatively tunes neuronal plasticity
in response to Ca2+ signalling. One of the recurrent
challenges is to identify the mechanisms through which
ROS act, whether these are direct redox modification
of effector proteins, or whether ROS impact on cellu-
lar function indirectly by modulating other signalling
pathways. For example, several protein phosphatases
(PP), including PP1 and PP2, PTEN and calcineurin
(PP 2B), are regulated by ROS, perhaps suggesting a
general role for ROS as negative regulators of kinase
cascade pathways [114–119]. In the capacity of phos-
phatase inhibitors ROS have modulatory access to
pathways known to regulate synaptic plasticity.
Indeed, in response to H2O2 application the phospho-
rylation state of ERK is upregulated in hippocampal
slices, cortical neurons and PC12 cells [120,121]. Simi-
larly, activation of PKC, which is required for hip-
pocampal LTP, is triggered by ROS [111] (Fig. 2).
Direct regulation of synaptic function by redox
modification of synaptic proteins also appears likely.
For example, exposure of frog NMJs to H2O2 revealed
their capability to directly regulate synaptic release
probabilities. While synaptic strength remained
unchanged, the authors observed altered quantal
release synchronicity when comparing proximal vs. dis-
tal parts of the NMJ, suggesting a modulatory role for
Fig. 2. ROS regulation of Synaptic Plasticity. (1) Presynaptic ROS, derived from mitochondria or NADPH oxidase activity regulates vesicle
release via oxidation of SNAP-25 [124]. ROS regulate release probabilities with subsynaptic terminal resolution [122,123]. (2) Increases in
ROS lead to activation of JNK and AP-1, which promote expression of antioxidant encoding genes [14] and others required for autophagy
[79]. AP-1 mediates neuronal adaptive responses to ROS [75,76]. (3) Postsynaptic LTP, in response to HFS, drives recruitment and opening
of NMDA receptors and consequent elevation of intracellular Ca2+ concentration. HFS causes elevated ROS production and a shift towards
an oxidative environment in the synaptic terminal (4) [83,92]. HFS-induced LTP requires ROS (5) [108] and exogenous application of ROS (6)
is sufficient to induce LTP in the absence of HFS [111]. ROS regulate canonical synaptic plasticity pathways via direct oxidative
modification, and inhibition of phosphatases PP1, PP2, PTEN and Calcineurin resulting in increased kinase signalling including ERK and PKC
(7) [114–121]. Also, ROS-activated PKC stimulates NADPH-oxidase activation and exacerbated ROS production (8) [107,111].
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ROS or redox state with subsynaptic resolution
[122,123]. In a follow-up study the same group identi-
fied SNAP-25, a component of the SNARE complex
and regulator of synaptic vesicle fusion, as a direct
ROS target, whose oxidation by H2O2 mediated down-
regulation of release synchronicity [124]. Excitingly, a
recent study demonstrated a role for targeted redox
modifications in regulating presynaptic homeostatic
adjustments of quantal content. Postsynaptic Sema-
phorin to presynaptic Plexin signalling activates the
MICAL monooxygenase. This is known to specifically
modify the actin cytoskeleton, which might impact on
the presynaptic cytoskeleton in general and actin-
mediated vesicle tethering in particular [125] (Fig. 2).
In summary, current evidence suggests that synaptic
plasticity is regulated by both direct and indirect
modes of ROS action. It will almost certainly be deter-
mined by context, such as local redox state of pre- or
postsynaptic sites, the nature (e.g. hydrogen peroxide
vs. superoxide vs. nitric oxide), source and subcellular
localisation of ROS (e.g. mitochondrial vs. plasma
membrane localised NADPH oxidase vs. cytoskeleton
associated monooygenase). In addition, different pro-
tein modifications might be subject to distinct ROS
concentration thresholds, which could endow ROS
signalling with a further degree of flexibility and
complexity.
Conclusions
A large body of work has demonstrated the impor-
tance of ROS as signals that regulate numerous pro-
cesses during neuronal development and nervous
system function. With the majority of work to date
having been carried out in cultured cells, it will be
important to verify these by studying ROS signalling
in vivo. While whole animal knockout mutants, for
example, of NADPH oxidases, are informative, future
work would ideally use cell-specific mosaic manipula-
tions with which to unambiguously determine cell type
specificity of ROS requirements. One central aspect
will be to determine how ROS generation is regulated,
for example, the subcellular localisation of NADPH
oxidases and other ROS generators. Previous studies
have reported cue-dependent changes in regulatory
subunits as mechanisms for controlling ROS produc-
tion [58,126]. Equally important for our understanding
will be genetically encoded tools for visualising ROS
and cellular redox potential, ideally with specificity for
different ROS species [127–130]. Under normal physio-
logical conditions ROS signals are expected to be con-
fined in space and time. In the nervous system, in
particular, there is a need for new reagents that will
allow genetically targeted in vivo manipulation of ROS
generators and scavengers with spatial and temporal
control appropriate for studying neuronal cell beha-
viour and synaptic transmission. Following the success
of optogenetic modulators of neuronal excitability, this
might take the route for engineering optogenetic solu-
tions for ROS generation and sequestration [131].
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